drugset / Trial / NCT03571282

Safety and Effectiveness of Intravitreal Conbercept for Exudative Circumscribed Choroidal Haemangioma

NCT03571282

Phase 0 Unknown 50 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

This prospective clinical trial aims to evaluate the safety and effectiveness study of intravitreal conbercept injection for exudative circumscribed choroidal haemangioma.

Timeline

Start
2018-06-06
Primary completion
2019-06-06
Completion
2019-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Conbercept Protein / enzyme biologic Intravitreal

Indications